Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauri R Varadhachary

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Radiation Oncology (London, England)|October 26, 2006
Concurrent capecitabine and upper abdominal radiation therapy is well toleratedPrajnan Das, Robert A Wolff, James L Abbruzzese, et al.
The American Journal of Surgical Pathology|June 15, 2017
Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant TherapyDeyali Chatterjee, Matthew H Katz, Wai Chin Foo, et al.
Cancer|June 1, 2007
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapySunil Krishnan, Vishal Rana, Nora A Janjan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluationGauri R Varadhachary, Dmitri Talantov, Martin N Raber, et al.
Plos One|February 11, 2017
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinomaQingqing Liu, John Stewart, Hua Wang, et al.
Digestive Diseases and Sciences|July 14, 2011
Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 casesAshwani K Singal, William A Ross, Praveen Guturu, et al.
The American Journal of Surgical Pathology|September 16, 2016
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for SurvivalSun Mi Lee, Matthew H G Katz, Li Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic CancerJennifer B Goldstein, Li Zhao, Xuemei Wang, et al.
The American Journal of Surgical Pathology|February 4, 2012
Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomyDeyali Chatterjee, Asif Rashid, Hua Wang, et al.
Histopathology|October 12, 2013
Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Radiation Oncology (London, England)|October 26, 2006
Concurrent capecitabine and upper abdominal radiation therapy is well toleratedPrajnan Das, Robert A Wolff, James L Abbruzzese, et al.
The American Journal of Surgical Pathology|June 15, 2017
Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant TherapyDeyali Chatterjee, Matthew H Katz, Wai Chin Foo, et al.
Cancer|June 1, 2007
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapySunil Krishnan, Vishal Rana, Nora A Janjan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluationGauri R Varadhachary, Dmitri Talantov, Martin N Raber, et al.
Plos One|February 11, 2017
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinomaQingqing Liu, John Stewart, Hua Wang, et al.
Digestive Diseases and Sciences|July 14, 2011
Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 casesAshwani K Singal, William A Ross, Praveen Guturu, et al.
The American Journal of Surgical Pathology|September 16, 2016
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for SurvivalSun Mi Lee, Matthew H G Katz, Li Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic CancerJennifer B Goldstein, Li Zhao, Xuemei Wang, et al.
The American Journal of Surgical Pathology|February 4, 2012
Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomyDeyali Chatterjee, Asif Rashid, Hua Wang, et al.
Histopathology|October 12, 2013
Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Pageof 12